Comprehending Data From Integrated Continuous Glucose Monitoring Devices and Developing a Management Plan for Patients With Type 2 Diabetes (Pharmacist Credit)

This activity is part 2 of a 3-part webinar curriculum.

This activity includes patient counseling video vignettes.

Program Description

Integrated continuous glucose monitoring (iCGM) devices can offer useful information in managing the care of patients with diabetes. There are multiple available devices, each with different features or functionalities, such as duration of use or providing alerts and alarms. It is important to use the data that come from an iCGM device. The ambulatory glucose profile (AGP) report offers insight on the daily trends of a patient’s glucose and can be used to determine a management plan for patients with type 2 diabetes. Recommendations are guided by time in range (TIR) targets that may differ for specific patients with diabetes, so individualizing the care is critical. Additional important metrics in understanding data from CGM devices and how to use the information to optimize the care of patients with diabetes will be covered. Included in this activity are counseling videos that offer important educational pearls on assisting patients with diabetes with understanding the data from their iCGM device.

Target audience: Retail pharmacists, health-system pharmacists, and pharmacy technicians

Type of activity: Application for pharmacists; knowledge for pharmacy technicians
Release date: May 6, 2022
Expiration date: May 6, 2023

Time to complete activity: 1.0 hour
Fee: Free

Educational Objectives

Pharmacist Educational Objectives
At the completion of this activity, participants will be able to:

• Interpret ambulatory glucose profile (AGP) reports to generate a management plan for patients with type 2 diabetes
• Determine time in range (TIR) target recommendations based on integrated continuous glucose monitoring use in patients with type 2 diabetes
• Apply the key concepts of AGP reports and TIR target recommendations to a given case scenario

Pharmacy Technician Educational Objectives
At the completion of this activity, participants will be able to:

• Recognize ambulatory glucose profile (AGP) reports for patients with type 2 diabetes and key features
• Recall the importance of time in range (TIR) target recommendations based on integrated continuous glucose monitoring use in patients with type 2 diabetes
• Review examples of cases that can be referred to the pharmacist to discuss the key concepts of AGP reports and TIR target recommendations

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hour (0.10 CEU) under the ACPE universal activity numbers 0290-0000-22-228-H01-P and 0290-0000-22-229-H01-T. The activity is available for CE credit through May 6, 2023.

Instructions for Completing the Activity and Receiving CPE Credit

To receive CPE credit, participants must complete the pretest, view the webinar in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.

Disclosures

Faculty

Sara (Mandy) Reece, PharmD, CDCES, BC-ADM, BCACP, FADCES, has the following relevant financial relationships with commercial interests to disclose:
Consultant: Sanofi, Novo Nordisk
Speakers Bureau: Novo Nordisk

Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Liza Patel, PharmD, RPh; Karleen Melody, PharmD; Crissy Wilson; Susan Pordon; Brianna Winters; and Chloe Taccetta have no relevant financial relationships with commercial interests to disclose.

Medical reviewer Joshua Neumiller, PharmD, CDCES, has the following relevant financial relationships with commercial interests to disclose:
Consultant: Sanofi, Novo Nordisk, Bayer
Speakers Bureau: Dexcom

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms